© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
March 04, 2021
Genetically-indexed inhibition of TNF-TNFR1 signaling was predicted to reduce the risk of Crohn’s disease and ulcerative colitis, and increased the risk of multiple sclerosis.
October 03, 2020
History of syncope was present in 17% of the Parkinson group who had an altered blood pressure regulation upon standing and in 10% of those without.
August 22, 2020
Considerable discrepancy found between overt clinical symptoms of laryngeal pathology and abnormalities observed during a task protocol.
July 23, 2020
The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.
April 27, 2020
The new approval is based on the result of 38 clinical trials involving more than 1000 patients.
April 16, 2020
Impulse control disorder symptoms also commonly found in Parkinson disease patients treated with dopamine agonists.
March 21, 2020
Study data suggested that up to 80% of patients with Parkinson disease may have ophthalmologic symptoms.
February 21, 2020
New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.
February 14, 2020
Patients in the treatment group had improved dyskinesia symptoms and off time.
February 11, 2020
A multifaceted care plan for patients is shown to improve both their quality of life and the burden of treatment for caregivers.